Jubilant Biosys Profile
Key Indicators
- Authorised Capital ₹ 258.00 Cr
as on 04-10-2024
- Paid Up Capital ₹ 252.14 Cr
as on 04-10-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 225.00 Cr
as on 04-10-2024
- Satisfied Charges ₹ 14.30 Cr
as on 04-10-2024
- Revenue 15.55%
(FY 2023)
- Profit -7.97%
(FY 2023)
- Ebitda -6.56%
(FY 2023)
- Net Worth 22.55%
(FY 2023)
- Total Assets 38.57%
(FY 2023)
About Jubilant Biosys
The Corporate was formerly known as Jubilant Biosys Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 258.00 Cr and a paid-up capital of Rs 252.14 Cr.
The company currently has active open charges totaling ₹225.00 Cr. The company has closed loans amounting to ₹14.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jubilant Biosys Limited India are Benny Thomas as CFO and Irfan Ali as Company Secretary. Arvind Chokhany, Prasant Deb, Gayatri Taragi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110UP1998PLC029591
- Company No.
029591
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Feb 1998
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jubilant Biosys?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giuliano Perfetti  | Managing Director | 27-Jan-2022 | Current |
Benny Thomas  | CFO | 20-Mar-2017 | Current |
| Irfan Ali | Company Secretary | 09-Jan-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gayatri Taragi | Director | 29-Apr-2023 | Current |
| Arvind Chokhany | Director | 03-Jun-2021 | Current |
| Prasant Deb | Whole-Time Director | 03-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Jubilant Biosys.
Jubilant Biosys Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.55% increase. The company also saw a slight decrease in profitability, with a 7.97% decrease in profit. The company's net worth Soared by an impressive increase of 22.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jubilant Biosys?
In 2022, Jubilant Biosys had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jubilant Generics LimitedActive 11 years 24 daysArvind Chokhany and Gayatri Taragi are mutual person
Jubilant Agro Sciences LimitedActive 3 years 6 monthsArvind Chokhany and Gayatri Taragi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 09 Aug 2022 | ₹125.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 24 Dec 2020 | ₹75.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 24 Dec 2020 | ₹25.00 Cr | Open |
How Many Employees Work at Jubilant Biosys?
Unlock and access historical data on people associated with Jubilant Biosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Biosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
